Literature DB >> 22814861

A case for reclassifying infiltrating gliomas in adults.

Nicholas F Marko, Robert J Weil.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22814861     DOI： 10.1007/s11060-012-0928-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  18 in total

1.  Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion.

Authors:  Robert C Rostomily; Donald E Born; Richard P Beyer; Jinghua Jin; Ellsworth C Alvord; Andrei M Mikheev; Russell T Matthews; Catherine Pan; Leila Khorasani; Josh A Sonnen; Thomas J Montine; Min Shi; Jing Zhang
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

2.  Can morphology predict 1p/19q loss in oligodendroglial tumours?

Authors:  D Scheie; M Cvancarova; S Mørk; K Skullerud; P A Andresen; I Benestad; E Helseth; T Meling; K Beiske
Journal:  Histopathology       Date:  2008-11       Impact factor: 5.087

Review 3.  Update on molecular findings, management and outcome in low-grade gliomas.

Authors:  T David Bourne; David Schiff
Journal:  Nat Rev Neurol       Date:  2010-11-02       Impact factor: 42.937

4.  Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.

Authors:  Constance A Griffin; Peter Burger; Laura Morsberger; Raluca Yonescu; Sharon Swierczynski; Jon D Weingart; Kathleen M Murphy
Journal:  J Neuropathol Exp Neurol       Date:  2006-10       Impact factor: 3.685

Review 5.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

6.  Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression.

Authors:  Rubén Ferrer-Luna; Manuel Mata; Lina Núñez; Jorge Calvar; Francisco Dasí; Eugenia Arias; José Piquer; Miguel Cerdá-Nicolás; Ana Lía Taratuto; Gustavo Sevlever; Bernardo Celda; Horacio Martinetto
Journal:  J Neurooncol       Date:  2009-07-12       Impact factor: 4.130

7.  Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.

Authors:  Nicholas F Marko; Richard A Prayson; Gene H Barnett; Robert J Weil
Journal:  Genomics       Date:  2009-10-14       Impact factor: 5.736

8.  Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.

Authors:  Matthias Preusser; Robert Charles Janzer; Jörg Felsberg; Guido Reifenberger; Marie-France Hamou; Annie-Claire Diserens; Roger Stupp; Thierry Gorlia; Christine Marosi; Harald Heinzl; Johannes A Hainfellner; Monika Hegi
Journal:  Brain Pathol       Date:  2008-04-08       Impact factor: 6.508

9.  Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues.

Authors:  Craig Horbinski; Julia Kofler; Lindsey M Kelly; Geoffrey H Murdoch; Marina N Nikiforova
Journal:  J Neuropathol Exp Neurol       Date:  2009-12       Impact factor: 3.148

10.  Age-related differences in 1p and 19q deletions in oligodendrogliomas.

Authors:  Yvonne Myal; Marc R Del Bigio; Roy H Rhodes
Journal:  BMC Clin Pathol       Date:  2003-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.